1 / 13

EVENT TITLE EVENT DATE

ADVANTAGE JA is a Joint Action co-funded by the EU and 22 Member States. It aims to promote a comprehensive approach to prevent frailty and promote a disability-free advanced age in Europe. The initiative involves 35 organizations and has a duration of three years.

hughesm
Télécharger la présentation

EVENT TITLE EVENT DATE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. EVENT TITLEEVENT DATE ADVANTAGE JA Joint Action on Prevention of frailty 2017-2019

  2. ADVANTAGE JA“A comprehensive approach to promote a disability-free Advanced age in Europe: the ADVANTAGE initiative” A Joint Action with 22 Member States and 35 organizations involved. It is co-funded by the EU and the Member States. • DURATION: 1stJanuary 2017 - 31stDecember 2019 (3 years) • COORDINATOR: Hospital de Getafe SERMAS, Madrid Spain • BUDGET: The estimated eligible costs of the action are EUR 5,738,934.60 (The grant reimburses 60% of the action's eligible costs)

  3. Other beneficiaries • MedizinischeUniversitat Graz (MUG), Austria; • InstitutScientifique de Sante Publique (WIV-ISP (IPH)), Belgium; • NatsionalenCentar Po ObshtestvenoZdrave i Analizi (NCPHA), Bulgaria; • HrvatskiZavod Za JavnoZdravstvo (CIPH), Croatia; • Ministry of Health of the Republic of Cyprus (MOH), Cyprus; • TerveydenJaHyvinvoinninLaitos (THL), Finland; • AgenceNationale De SantePublique (ANSP), France; • Ministere des Affaires Sociales et de la Sante (MASSDF), France; • MedizinischeHochschule Hannover (MHH), Germany; • Company of Psychosocial Research and Intervention (EPSEP) (SPRI), Greece; • Panepistimio Patron (UPAT), Greece; • NemzetiEgeszsegfejlesztesiIntezet (NIHD), Hungary; • Health Service Executive HSE (HSE-NUIG), Ireland; • Agenzia Nazionale per i Servizi Sanitari Regionali (AGENAS), Italy; • Istituto Nazionale di Riposo e Cura per Anziani INRCA (INRCA), Italy; • Istituto Superiore di Sanita (ISS), Italy; • Regione Marche (ARS), Italy; • Universita Cattolica del Sacro Cuore (UCSC), Italy; • LietuvosSveikatosMoksluUniversitetas (LSMU), Lithuania; • Ministry for the Family and Social Solidarity (MFSS), Malta; • RijksinstituutvoorVolksgezondheid en Milieu (RIVM), Netherlands; • Folkehelseinstituttet (NIPH Norway), Norway; • NarodowyInstytutGeriatriiReumatologiiiRehabilitacjiIm.Prof.Dr Hab. Med. EleonoryReicher (NIGRiR), Poland; • Ministerio da Saude - RepublicaPortuguesa (DGS), Portugal; • Centrul National de SanatateMintala si LuptaAntidrog (CNSM), Romania; • ScoalaNationala de SanatatePublica, Management si Perfectionare in Domeniul Sanitar Bucuresti (SNSPMPDSB), Romania; • UniversitateaBabesBolyai (UBB), Romania; • NacionalniInštitutZa JavnoZdravje (NIJZ), Slovenia; • Asociacion Centro de ExcelenciaInternacional en InvestigacionSobreCronicidad (KRONIKGUNE), Spain; • Consejeria de Salud de la Junta de Andalucia (CSJA), Spain; • Fundacion para la Investigacion del Hospital Clinico de la ComunitatValenciana, FundacionIncliva (INCLIVA), Spain; • NHS Lanarkshire (NHS LANARKSHIRE), United Kingdom. AFFILIATED ENTITIES • Fundacion Para La Investigacion Biomedica Del Hospital Universitario De Getafe (FIBHUG), Spain; • Servicio de Salud de Castilla la Mancha (SESCAM), Spain; • Servicio Vasco de SaludOsakidetza (Osakidetza), Spain; • Servicio Andaluz de Salud (SAS), Spain; • FundacionPublicaAndaluzaProgreso y Salud (FPS), Spain; • StatniZdravotniUstav (NIPH), Czech Republic; • Azienda Ospedaliera Universitaria Federico II (FEDERICO II), Italy; • Istituto di Ricerche Economico Sociali del Piemonte (IRES Piemonte), Italy; • Regione Emilia Romagna (RER-ASSR), Italy; • Regione Liguria (Liguria), Italy; • Svim – Sviluppo Marche Spa Società Unipersonale (SVIM), Italy.

  4. WHY FRAILTY? Demographic trends suggest: • an increase in age-related disability and dependence • impact on the wellbeing of the individuals affected • impact on the sustainability of healthcare systems The number of people 65+ is predicted to rise from 18% to28% by 2060 (12% of people 80+) We need to re-shape healthcare systems to better address the needs of older people!!

  5. Objectives • To promote important sustainable changes in the organization and implementation of care in the Health and Social Systems; • To prepare a common European framework on screening, early diagnosis, prevention, assessment and management of frailty; • To develop a common strategy on frailty prevention and management, including raising awareness and advocacy among stakeholders, especially policy and decision makers. ADVANTAGE JA aims at building a common understanding on frailty to be used in all the Member States, by policy makers and other stakeholders, which should be the base for a common management both at individual and population level of older people who are frail or at risk of developing frailty throughout the European Union.

  6. TARGET GROUPS Policy makers and stakeholders, both from the public and private sectors. Health and Social care professionals and formal and informal carers. Frail older people and their carers, and those at risk of frailty, and the EU population at large. Icon made by Freepik from www.flaticon.com

  7. How is ADVANTAGE JA structured ? Work packages • It will develop the concept of the ‘Frailty Prevention Approach’ (FPA) in health and social care services. • It will build consensus on the convenience of addressing frailty independently from long-term conditions & chronic diseases.

  8. IMPLEMENTATION PHASES • Phase I (2017) - State of the Art - background information collection, analysis and rational discussion and drafting of preliminary documents. • Phase II (2018) - developing and testing the draft version of the common European model to approach frailty (frailty prevention approach – FPA document). Phase III (2019) - drafting final documents, debating these with participant MSs, and drafting the final framework, the FPA document and policy recommendations.

  9. EXPECTED OUTCOMES /RESULTS • A GENERAL EUROPEAN FRAMEWORK • A common European model to tackle frailty: • The Frailty Prevention Approach (FPA) document. A SPECIFIC MS PERSPECTIVE Implementing the European model according to local capability and context.

  10. EXPECTED OUTCOMES /RESULTS • Develop and encourage consensus in the concept of the Prevention of Frailtyin health and social care services. • Improved strategies for diagnosis, care, research, and education about frailty, disability and multi-morbidity. Reduce the burden and inefficiency in care delivery, through support for self-management, better care planning and coordination. Contribute to a more effective and sustainable response to the needs of older people with innovative organisational approaches and better collaboration between professional and informal care.

  11. EU ADDED VALUE • Addresses common challenges where shared action at EU level may • facilitate development of national frailty prevention policies. • Addresses demographic change & associated demands for social & • health care by re-shaping health care. • Jointly tackles a common public health problem (frailty, discapacity) • by avoiding scattered actions or duplications. • Develops the FPA concept in health & social services by encouraging • consensus and developing common frameworks on screening, • prevention, assessment and management. Icon made by Freepik from www.flaticon.com

  12. ADVANTAGE JA DISSEMINATION • Website www.advantageja.eu • Social Networks: • Facebook: https://www.facebook.com/advantageJA/ • Linkedin: https://www.linkedin.com/company/advantage-joint-action/ • Twitter:https://twitter.com/Advantage_JA • E-newsletters • Publications • Participation at events • Final Conference in Bruxelles • Leaflet • Policy Briefs • Layman Reports Media: Press releases/conferences Radio/TV

  13. THANK YOU !!!www.advantageja.eu Insert speaker/s name/s and email address

More Related